Patient characteristics in persistent pulmonary hypertension of the newborn

M T R Roofthooft1, A Elema, K A Bergman

  • 1Department of Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.

Pulmonary Medicine
|June 11, 2011
PubMed

Insights

Persistent pulmonary hypertension of the newborn (PPHN) is a serious condition, particularly in preterm infants. In term survivors, PPHN did not significantly impact long-term morbidity or outcomes.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Pulmonology

Background:

  • Persistent pulmonary hypertension of the newborn (PPHN) is a critical neonatal condition with significant mortality risks.
  • Understanding the factors influencing PPHN outcomes is crucial for improving neonatal care.

Purpose of the Study:

  • To evaluate the effects of PPHN on mortality, morbidity, and behavioral development in newborns.
  • To identify risk factors associated with PPHN-related mortality.

Main Methods:

  • A retrospective observational study involving 143 newborns diagnosed with PPHN over 11 years.
  • Utilized objective health data from medical records and subjective data from the Child Behaviour Checklist.

Main Results:

  • Male infants, those treated with inhaled nitric oxide (iNO), and those with maladaptation/maldevelopment were common. Gestational age >37 weeks was noted.
  • In term newborns, pathophysiological mechanism and Oxygen Index were independent predictors of PPHN-related mortality.
  • No significant correlation was found between iNO use and respiratory complaints in term survivors after multivariate analysis.

Conclusions:

  • PPHN remains a severe and potentially fatal condition, with a high incidence in preterm infants.
  • In term survivors, PPHN did not appear to have an additional impact on morbidity or overall outcome.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.